Back to search
FDAFDA · Food and drugs·Recall number D-0898-2018

Norepinephrine Bitartrate 4 mg (16 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT

Published July 11, 2018 · Recall initiated: June 14, 2018

Summary

FDA records drug Class II recall D-0898-2018, published July 11, 2018 and initiated June 14, 2018. Recalling firm: SCA Pharmaceuticals, LLC; Status: Terminated; Reported quantity: 2,268 bags; Lot: Lot # 1218000928, 1218000944, 1218000945, 1218001075, 1218001076, 1218001188, Exp 06/19/2018-07/03/2018. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
SCA Pharmaceuticals, LLC
Distributor
Product was distributed throughout the United States.
Lot
Lot # 1218000928, 1218000944, 1218000945, 1218001075, 1218001076, 1218001188, Exp 06/19/2018-07/03/2018
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Norepinephrine Bitartrate 4 mg (16 mcg/mL) in 0.9% Sodium Chloride 250 mL bag, SCA Pharmaceuticals, LLC, Windsor, CT recalled?

Yes. FDA published recall D-0898-2018 on July 11, 2018. Reported hazard: Lack of Assurance of Sterility: SCA is conducting a voluntary recall of certain lots of sterile admixtures due to a potential for leakage.

What should I do if I have this product?

Voluntary: Firm initiated · Letter